Julie Bowen

670 total citations
15 papers, 383 citations indexed

About

Julie Bowen is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Cancer Research. According to data from OpenAlex, Julie Bowen has authored 15 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 7 papers in Radiation and 4 papers in Cancer Research. Recurrent topics in Julie Bowen's work include Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (8 papers) and Advanced Radiotherapy Techniques (7 papers). Julie Bowen is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (8 papers) and Advanced Radiotherapy Techniques (7 papers). Julie Bowen collaborates with scholars based in Canada, United Kingdom and Switzerland. Julie Bowen's co-authors include Charles Ludgate, Shawn Malone, Gad Perry, Gina Lockwood, Juanita Crook, Libni Eapen, Susan J. Robertson, Juanita Crook, Susan J. Robertson and L. Eapen and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Julie Bowen

14 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Bowen Canada 9 307 119 70 52 51 15 383
Jure Murgić Croatia 10 254 0.8× 112 0.9× 38 0.5× 55 1.1× 66 1.3× 53 400
Pervin Hürmüz Türkiye 12 239 0.8× 89 0.7× 53 0.8× 89 1.7× 61 1.2× 55 381
Ali Hasbini France 13 346 1.1× 72 0.6× 68 1.0× 104 2.0× 137 2.7× 47 502
Shaun Tolan United Kingdom 10 184 0.6× 53 0.4× 37 0.5× 109 2.1× 52 1.0× 15 283
Tanja Baresic Italy 12 461 1.5× 87 0.7× 36 0.5× 59 1.1× 79 1.5× 20 601
Bruce Hershatter United States 7 191 0.6× 50 0.4× 39 0.6× 33 0.6× 28 0.5× 29 270
Meryem Brihoum France 8 414 1.3× 115 1.0× 68 1.0× 67 1.3× 54 1.1× 12 470
Palak Popat India 11 242 0.8× 116 1.0× 37 0.5× 105 2.0× 74 1.5× 47 419
N. Pimentel Portugal 11 227 0.7× 132 1.1× 58 0.8× 63 1.2× 99 1.9× 25 400
Marlon Silva France 8 384 1.3× 113 0.9× 55 0.8× 43 0.8× 28 0.5× 16 412

Countries citing papers authored by Julie Bowen

Since Specialization
Citations

This map shows the geographic impact of Julie Bowen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Bowen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Bowen more than expected).

Fields of papers citing papers by Julie Bowen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Bowen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Bowen. The network helps show where Julie Bowen may publish in the future.

Co-authorship network of co-authors of Julie Bowen

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Bowen. A scholar is included among the top collaborators of Julie Bowen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Bowen. Julie Bowen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bowen, Julie, et al.. (2025). Colorectal and anal cancer patients experiences during pelvic radiotherapy: a service evaluation. Journal of Radiotherapy in Practice. 24.
2.
Whelan, Timothy J., Sally Smith, Torsten O. Nielsen, et al.. (2022). LUMINA: A prospective trial omitting radiotherapy (RT) following breast conserving surgery (BCS) in T1N0 luminal A breast cancer (BC).. Journal of Clinical Oncology. 40(17_suppl). LBA501–LBA501. 31 indexed citations
4.
Malone, Shawn, Soumyajit Roy, Libni Eapen, et al.. (2019). Sequencing of Androgen-Deprivation Therapy With External-Beam Radiotherapy in Localized Prostate Cancer: A Phase III Randomized Controlled Trial. Journal of Clinical Oncology. 38(6). 593–601. 33 indexed citations
5.
Pearce, Andrew, et al.. (2013). Evaluation of Canada's First Radiation Oncology Treatment Facility Operated by Telemedicine. International Journal of Radiation Oncology*Biology*Physics. 87(2). S485–S485. 2 indexed citations
6.
Alexander, Abraham, Juanita Crook, Stuart Jones, et al.. (2009). Is Biochemical Response More Important Than Duration of Neoadjuvant Hormone Therapy Before Radiotherapy for Clinically Localized Prostate Cancer? An Analysis of the 3- Versus 8-Month Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 76(1). 23–30. 50 indexed citations
7.
Crook, Juanita, Charles Ludgate, Shawn Malone, et al.. (2008). Final Report of Multicenter Canadian Phase III Randomized Trial of 3 Versus 8 Months of Neoadjuvant Androgen Deprivation Therapy Before Conventional-Dose Radiotherapy for Clinically Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 73(2). 327–333. 88 indexed citations
8.
Whelan, Timothy J., Jean‐Philippe Pignol, Jim A. Julian, et al.. (2008). Long-term Results of a Randomized Trial of Accelerated Hypofractionated Whole Breast Irradiation Following Breast Conserving Surgery in Women with Node-Negative Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 72(1). S28–S28. 22 indexed citations
9.
Crook, John M., Charles Ludgate, Shawn Malone, et al.. (2008). Final Report of a Canadian Phase III Trial of 3 vs 8 months Neoadjuvant Androgen Deprivation Prior to 66 Gray External Beam Radiotherapy for Clinically Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 72(1). S75–S75. 2 indexed citations
10.
Crook, Juanita, Charles Ludgate, Shawn Malone, et al.. (2004). Report of a multicenter Canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancer. International Journal of Radiation Oncology*Biology*Physics. 60(1). 15–23. 86 indexed citations
11.
Crook, Juanita, Charles Ludgate, Jae Hoon Lim, et al.. (2002). Preliminary report of a multi center canadian phase III randomized trial of 3 months vs 8 months neoadjuvant androgen ablation prior to standard dose radiotherapy for clinically localized prostate cancer. International Journal of Radiation Oncology*Biology*Physics. 54(2). 134–134. 3 indexed citations
12.
Pickles, Tom, George Goodman, Chris Fryer, et al.. (1999). Pion conformal radiation of prostate cancer: results of a randomized study. International Journal of Radiation Oncology*Biology*Physics. 43(1). 47–55. 22 indexed citations
13.
Goodman, George, D. Rheaume, Graeme Duncan, et al.. (1997). Pion radiation for high grade astrocytoma: Results of a randomized study. International Journal of Radiation Oncology*Biology*Physics. 37(3). 491–497. 27 indexed citations
14.
Bowen, Julie, et al.. (1991). Pions — The potential for therapeutic gain in locally advanced prostate cancer: Dose escalation and toxicity studies. International Journal of Radiation Oncology*Biology*Physics. 21(4). 1005–1011. 9 indexed citations
15.
Goodman, George, Julie Bowen, Peter Dixon, et al.. (1990). PIMESON RADIOTHERAPY AT TRIUMF. 2(2). 85–99. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026